MedTrace Logo

Efficacy of Iodine Complex Against COVID-19 Patients

NCT04473261 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2021-07-07

No results posted yet for this study

Summary

The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.

Conditions

Interventions

DRUG

Iodine Complex

Iodine Complex capsule (200mg) will be given three times a day

DRUG

Iodine Complex

Iodine Complex syrup form (40ml) will be given three times a day

DRUG

Placebo

Empty capsule will be given as placebo

DRUG

Idoine Complex

Iodine Complex spray form 2 puffs will be given three times a day

Sponsors & Collaborators

  • Sohaib Ashraf

    lead OTHER

Principal Investigators

  • Muhammad Ashraf, PhD · University of Veterinary & Animal Sciences, Pakistan

  • Shoaib Ashraf, PhD · Harvard University, Massachusetts General Hospital, Boston, USA

  • Moneeb Ashraf, MBBS · Mayo Hospital, Pakistan

  • Sohaib Ashraf, MBBS · Shaikh Zayed Medical Complex, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-14
Primary Completion
2021-08-15
Completion
2021-10-15

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04473261 on ClinicalTrials.gov